Filter by: patients
Home > Community Treatment Reports and Side Effects > CERE-120 Treatment Report
What is CERE-120?

CERE-120 uses gene therapy to deliver the neural growth factor neurturin to the major area of neurodegeneration that occurs in the brains of Parkinson's disease patients.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Parkinson's Disease 2 0
Other 1 0

See all 3 patients currently taking CERE-120

Mouse over the table for more information

Reported Dosages

  0tbs. as needed
  1 Number of Patients: 1  

Report created on May 28, 2012.